Paper29367757
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
Hu T and 7 others. Oncogene, 2018. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase. Papers, record 29367757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367757
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma | Major topic |
| MicroRNAs | Major topic |
| Oncogene Proteins, Fusion | Major topic |
| Proto-Oncogene Proteins c-bcr | Major topic |
| Receptor, Fibroblast Growth Factor, Type 1 | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| HEK293 Cells | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Multigene Family | |
| Syndrome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA076167 | NCI NIH HHS | United States | R01CA076167 | PubMed and NIH |
Source NIH RePORTER
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24479800 | Oncogenic microRNAs in the genesis of leukemia and lymphoma. | Curr Pharm Des | 2014 | https://conductscience.org/library/papers/24479800 | PubMed |
| 2 | 26555894 | miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth. | Nat Commun | 2015 | https://conductscience.org/library/papers/26555894 | PubMed |
| 3 | 20008931 | Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. | Genes Dev | 2009 | https://conductscience.org/library/papers/20008931 | PubMed |
| 4 | 21045193 | The prognostic and functional role of microRNAs in acute myeloid leukemia. | Blood | 2011 | https://conductscience.org/library/papers/21045193 | PubMed |
| 5 | 24169826 | The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. | Blood | 2013 | https://conductscience.org/library/papers/24169826 | PubMed |
| 6 | 20133587 | Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133587 | PubMed |
| 7 | 24382515 | MicroRNA-210 overexpression predicts poorer prognosis in glioma patients. | J Clin Neurosci | 2014 | https://conductscience.org/library/papers/24382515 | PubMed |
| 8 | 27391347 | SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models. | Oncotarget | 2016 | https://conductscience.org/library/papers/27391347 | PubMed |
| 9 | 23318438 | WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. | Oncogene | 2014 | https://conductscience.org/library/papers/23318438 | PubMed |
| 10 | 22238599 | Rapid generation of microRNA sponges for microRNA inhibition. | PLoS One | 2012 | https://conductscience.org/library/papers/22238599 | PubMed |
| 11 | 17694064 | MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. | Nat Methods | 2007 | https://conductscience.org/library/papers/17694064 | PubMed |
| 12 | 27280396 | Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles. | Cancer Res | 2016 | https://conductscience.org/library/papers/27280396 | PubMed |
| 13 | 26589915 | FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model. | Haematologica | 2016 | https://conductscience.org/library/papers/26589915 | PubMed |
| 14 | 20851997 | The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. | Cancer Res | 2010 | https://conductscience.org/library/papers/20851997 | PubMed |
| 15 | 20388800 | Oncogenic role of miR-483-3p at the IGF2/483 locus. | Cancer Res | 2010 | https://conductscience.org/library/papers/20388800 | PubMed |
| 16 | 20226962 | 8p11 myeloproliferative syndrome: a review. | Hum Pathol | 2010 | https://conductscience.org/library/papers/20226962 | PubMed |
| 17 | 27785808 | A model of BCR-FGFR1 driven human AML in immunocompromised mice. | Br J Haematol | 2016 | https://conductscience.org/library/papers/27785808 | PubMed |
| 18 | 12969958 | FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice. | Blood | 2004 | https://conductscience.org/library/papers/12969958 | PubMed |
| 19 | 23967867 | MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. | J Transl Med | 2013 | https://conductscience.org/library/papers/23967867 | PubMed |
| 20 | 22701616 | Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage. | PLoS One | 2012 | https://conductscience.org/library/papers/22701616 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42933890 | CBFB-MYH11 directly activates TGFβ and PD-L1 to drive immune evasion in acute myeloid leukemia. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42933890 | PubMed |
| 42650865 | MicroRNAs: A Social Network in Diabetic Retinopathy. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650865 | PubMed |
| 39807336 | Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil via targeting KDM4C/MIR17HG/GSK-3β negative feedback loop in colorectal cancer. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39807336 | PubMed |
| 36924298 | FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/36924298 | PubMed |
| 36408177 | The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36408177 | PubMed |
| 34906138 | IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies. | Mol Cancer | 2021 | https://conductscience.org/library/papers/34906138 | PubMed |
| 33305460 | Deciphering the role of microRNAs in mustard gas-induced toxicity. | Ann N Y Acad Sci | 2021 | https://conductscience.org/library/papers/33305460 | PubMed |
| 31628193 | DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31628193 | PubMed |
| 31361891 | Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications. | J Mol Cell Biol | 2019 | https://conductscience.org/library/papers/31361891 | PubMed |
| 31105873 | BCR: a promiscuous fusion partner in hematopoietic disorders. | Oncotarget | 2019 | https://conductscience.org/library/papers/31105873 | PubMed |
| 30854399 | The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/30854399 | PubMed |
| 30413411 | Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice. | Cancer Res | 2019 | https://conductscience.org/library/papers/30413411 | PubMed |
| 29735550 | miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes. | Cancer Res | 2018 | https://conductscience.org/library/papers/29735550 | PubMed |
| 29720732 | FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome. | Leukemia | 2018 | https://conductscience.org/library/papers/29720732 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29367757
GET https://conductscience.org/api/papers/v1/29367757/references?page=2